Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Long Beach, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Oxnard, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Pasadena, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Reseda, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Reseda, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Sunnyvale, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Ventura, CA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Ventura, CA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Fairfield, CT
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Fairfield, CT
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Bradenton, FL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Augusta, GA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Chicago, IL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Winfield, IL
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Winfield, IL
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Des Moines, IA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kansas City, KA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Toms River, NJ
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Durham, NC
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Raleigh, NC
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Toledo, OH
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Houston, TX
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
San Antonio, TX
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Richmond, VA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kirkland, WA
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
West Bloomfield, MI
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously and Intranasally in Patients With Parkinson's Disease
Status: Enrolling
Updated:  11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously and Intranasally in Patients With Parkinson's Disease
Status: Enrolling
Updated: 11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Associated Neurologists of Southern Ct., PC
mi
from
Fairfield, CT
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Associated Neurologists of Southern Ct., PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Hoag Memorial Hospital Presbyterian
mi
from
Newport Beach, CA
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Hoag Memorial Hospital Presbyterian
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
University of Toledo, Gardner-McMaster Parkinson Center
mi
from
Toledo, OH
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
University of Toledo, Gardner-McMaster Parkinson Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
University of Toledo, Investigational Drug Services
mi
from
Toledo, OH
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
University of Toledo, Investigational Drug Services
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
The Movement Disorder Clinic of Oklahoma
mi
from
Tulsa, OK
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
The Movement Disorder Clinic of Oklahoma
mi
from
Tulsa, OK
Click here to add this to my saved trials
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated:  12/1/2017
Booth Gardner Parkinson's Care Center
mi
from
Kirkland, WA
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease
Status: Enrolling
Updated: 12/1/2017
Booth Gardner Parkinson's Care Center
mi
from
Kirkland, WA
Click here to add this to my saved trials
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
Status: Enrolling
Updated:  12/4/2017
NYU Medical Center
mi
from
New York, NY
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
Status: Enrolling
Updated: 12/4/2017
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
Status: Enrolling
Updated:  12/5/2017
University of Miami
mi
from
Miami, FL
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
Status: Enrolling
Updated: 12/5/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Treating Bacterial Overgrowth in Parkinson's Disease
Treating Bacterial Overgrowth in Parkinson's Disease
Status: Enrolling
Updated:  12/7/2017
University of Cincinnati
mi
from
Cincinnati, OH
Treating Bacterial Overgrowth in Parkinson's Disease
Treating Bacterial Overgrowth in Parkinson's Disease
Status: Enrolling
Updated: 12/7/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study
Status: Enrolling
Updated:  12/7/2017
Johns Hopkins Medical Institutes
mi
from
Baltimore, MD
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study
Status: Enrolling
Updated: 12/7/2017
Johns Hopkins Medical Institutes
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
Status: Enrolling
Updated:  12/8/2017
University of Chicago Medical Center
mi
from
Chicago, IL
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
Status: Enrolling
Updated: 12/8/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Guided Self-Help for Depression in Parkinson's Disease
A Guided Cognitive-Behavioral Self-Help Treatment for Depression in Parkinson's Disease
Status: Enrolling
Updated:  12/10/2017
Rutgers University-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Guided Self-Help for Depression in Parkinson's Disease
A Guided Cognitive-Behavioral Self-Help Treatment for Depression in Parkinson's Disease
Status: Enrolling
Updated: 12/10/2017
Rutgers University-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Sunnyvale, CA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Foxboro, MA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Foxboro, MA
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Cleveland, OH
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Tulsa, OK
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Austin, TX
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials